- Home
- LBRX vs GRNT Comparison
LBRX vs GRNT Comparison
Compare LBRX & GRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LBRX | GRNT |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 602.6M | 662.8M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | LBRX | GRNT |
|---|---|---|
| Price | $23.91 | $5.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $49.00 | $8.00 |
| AVG Volume (30 Days) | 181.2K | ★ 611.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.77% |
| EPS Growth | N/A | ★ 28.57 |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $450,306,000.00 |
| Revenue This Year | N/A | $16.85 |
| Revenue Next Year | N/A | $5.78 |
| P/E Ratio | ★ N/A | $27.64 |
| Revenue Growth | N/A | ★ 18.49 |
| 52 Week Low | $13.40 | $4.18 |
| 52 Week High | $25.60 | $6.59 |
Technical Indicators
Market Signals| Indicator | LBRX | GRNT |
|---|---|---|
| Relative Strength Index (RSI) | 52.85 | 50.03 |
| Support Level | $22.34 | $4.86 |
| Resistance Level | $24.70 | $5.45 |
| Average True Range (ATR) | 1.26 | 0.21 |
| MACD | -0.14 | -0.01 |
| Stochastic Oscillator | 51.76 | 49.32 |
Price Performance
Historical ComparisonAbout LBRX LB Pharmaceuticals Inc
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.
About GRNT Granite Ridge Resources Inc.
Granite Ridge Resources Inc is a scaled, non-operated oil and gas exploration and production company. It invests in a diversified portfolio of production and top-tier acreage across the Permian and other prolific U.S. basins in partnership with operators. It generates maximum revenue from Oil.